Abstract:Summary Background This study aimed to: 1) assess the associations of biological age acceleration based on Klemera and Doubal's method (KDM-AA) with long-term risk of all-cause mortality; and 2) compare the association of KDM-AA with all-cause mortality among participants potentially at different stages of the cardiovascular disease (CVD) continuum. Methods The present study was based on a subpopulation of the China Kadoorie Biobank, with baseline survey during 2004–08. A total of 12,377 participants free of ischemic heart disease, stroke, or cancer at baseline were included, in which 8180 participants were identified to develop major coronary event (MCE), ischemic stroke (IS), intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH), and 4197 remained free of these cardiovascular diseases before 1 January 2014. These participants were followed up until 1 Jan 2018. KDM-AA was calculated by regressing biological age measurement, which was constructed based on baseline 16 physical and 9 biochemical markers using Klemera and Doubal's method, on chronological age. We estimated the associations of KDM-AA with the mortality risk using the hazard ratio (HR) and 95% confidence interval (CI) from Cox proportional hazard models. We assessed discrimination performance by Harrell's C-index and net reclassification index (NRI). Findings The participants who developed MCE (mean KDM-AA = 0.1 year, standard deviation [SD] = 1.6 years) or ICH/SAH (0.3 ± 1.5 years) during subsequent follow-up showed accelerated aging at baseline compared to those of IS (0.0 ± 1.2 years) and control (−0.3 ± 1.3 years) groups. The KDM-AA was positively associated with long-term risk of all-cause mortality (HR = 1.20; 95% CI: 1.17, 1.23), and the association was robust for participants potentially at different stages of the CVD continuum. Adding KDM-AA improved mortality prediction compared to the model only with sociodemographic and lifestyle factors in whole participants, with the Harrell's C-index increasing from 0.813 (0.807, 0.819) to 0.821 (0.815, 0.826) (NRI = 0.011; 95% CI: 0.003, 0.019). Interpretation In this middle-aged and elderly Chinese population, the KDM-AA is a promising measurement for biological age, and can capture the difference in cardiovascular health and predict the risk of all-cause mortality over a decade. Funding This work was supported by National Natural Science Foundation of China ( 82192904 , 82192901 , 82192900 , 81941018 ). The CKB baseline survey and the first re-survey were supported by a grant from the Kadoorie Charitable Foundation Hong Kong . The long-term follow-up is supported by grants from the UK Wellcome Trust ( 212946/Z/18/Z , 202922/Z/16/Z , 104085/Z/14/Z , 088158/Z/09/Z ), grants ( 2016YFC0900500 ) from the National Key R&D Program of China , National Natural Science Foundation of China ( 81390540 , 91846303 ), and Chinese Ministry of Science and Technology ( 2011BAI09B01 ).

Distinct biological ages of organs and systems identified from a multi-omics study

An evaluation of aging measures: from biomarkers to clocks

Model Construction for Biological Age Based on a Cross-Sectional Study of a Healthy Chinese Han Population.

Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality

Models for Evaluation of Biological Age Based on Multi-omics

Progress in biological age research

Biological age models based on a healthy Han Chinese population

The Genetic Architecture of Biological Age in Nine Human Organ Systems

Systems Age: A single blood methylation test to quantify aging heterogeneity across 11 physiological systems

Multiorgan Biological Age Shows That No Organ System is an Island

Organ-specific biological clocks: Ageotyping for personalized anti-aging medicine

High-dimensional Ageome Representations of Biological Aging across Functional Modules

Association of Biological Age with Health Outcomes and Its Modifiable Factors.

The biological age model for evaluating the degree of aging in centenarians

Plasma Proteomics-Based Organ-Specific Aging for All-Cause Mortality and Cause-Specific Mortality: a Prospective Cohort Study

Modeling biological age using blood biomarkers and physical measurements in Chinese adults

Lifestyles and their relative contribution to biological aging across multiple organ systems: change analysis from the China Multi-Ethnic Cohort Study

A Biological Age Model Based on Physical Examination Data to Predict Mortality in a Chinese Population

Biologically informed machine learning modeling of immune cells to reveal physiological and pathological aging process

Ageing hallmarks exhibit organ-specific temporal signatures

Blood Omics Models for System-Specific Mortality Risk Estimation